Medpace Holdings Net Profit Margin 2014-2024 | MEDP

Current and historical net profit margin for Medpace Holdings (MEDP) from 2014 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Medpace Holdings net profit margin for the three months ending September 30, 2024 was .
Medpace Holdings Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $2.07B $0.37B 17.63%
2024-06-30 $2.03B $0.34B 16.76%
2024-03-31 $1.96B $0.31B 15.95%
2023-12-31 $1.89B $0.28B 15.01%
2023-09-30 $1.78B $0.27B 15.38%
2023-06-30 $1.67B $0.27B 16.08%
2023-03-31 $1.56B $0.26B 16.44%
2022-12-31 $1.46B $0.25B 16.78%
2022-09-30 $1.38B $0.23B 16.44%
2022-06-30 $1.29B $0.21B 16.24%
2022-03-31 $1.21B $0.20B 16.47%
2021-12-31 $1.14B $0.18B 15.92%
2021-09-30 $1.09B $0.18B 16.64%
2021-06-30 $1.03B $0.17B 16.93%
2021-03-31 $0.96B $0.16B 16.54%
2020-12-31 $0.93B $0.14B 15.55%
2020-09-30 $0.90B $0.12B 13.84%
2020-06-30 $0.88B $0.11B 12.13%
2020-03-31 $0.89B $0.11B 12.35%
2019-12-31 $0.86B $0.10B 11.61%
2019-09-30 $0.82B $0.09B 11.18%
2019-06-30 $0.79B $0.09B 11.07%
2019-03-31 $0.74B $0.08B 10.38%
2018-12-31 $0.70B $0.07B 10.37%
2018-09-30 $0.63B $0.06B 9.92%
2018-06-30 $0.56B $0.05B 9.52%
2018-03-31 $0.49B $0.05B 9.33%
2017-12-31 $0.44B $0.04B 8.92%
2017-09-30 $0.43B $0.03B 6.48%
2017-06-30 $0.43B $0.02B 5.36%
2017-03-31 $0.43B $0.02B 4.20%
2016-12-31 $0.42B $0.01B 3.08%
2016-06-30 $0.30B $0.01B 2.68%
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00